Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever

Acta Tropica

Volumn 149, Issue , 2015, Pages 138-147

  Ferreira, Ralph Antonio Xavier ^a   de Oliveira, Solange Artimos ^a   Gandini, Mariana ^b   Ferreira, Laura da Cunha ^a   Correa, Gladys ^b   Abiraude, Fernanda Mattos ^b   Reid, Mariana Mancebo ^c   Cruz, Oswaldo Gonçalves ^b   Kubelka, Claire Fernandes ^b  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Hospital Municipal Jesus   (Brazil)

Author keywords

Brazil; Chemokines; Children; Cytokines; Dengue; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 13; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA; CXCL10 PROTEIN, HUMAN; ISOMERASE; MIF PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

CHILD HEALTH; DENGUE FEVER; DIGESTIVE SYSTEM DISORDER; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC;

ARTICLE; ASCITES; BRAZILIAN; CHILD; CONTROLLED STUDY; DENGUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMATOLOGIC DISEASE; HEPATOMEGALY; HUMAN; HYPOTENSION; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PLASMA LEAKAGE; THROMBOCYTE COUNT; ACUTE DISEASE; ADOLESCENT; BRAZIL; CAPILLARY PERMEABILITY; COHORT ANALYSIS; COMPLICATION; EPIDEMIC; IMMUNOLOGY; INFANT; LIVER DISEASES; METABOLISM; PLEURAL EFFUSION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEVERE DENGUE;

BRAZIL; RIO DE JANEIRO [BRAZIL];

ARTHROPODA;

ACUTE DISEASE; ADOLESCENT; ALANINE TRANSAMINASE; ASCITES; ASPARTATE AMINOTRANSFERASES; BRAZIL; CAPILLARY PERMEABILITY; CHEMOKINE CXCL10; CHEMOKINES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOKINES; DENGUE; EPIDEMICS; FEMALE; HEPATOMEGALY; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-13; INTRAMOLECULAR OXIDOREDUCTASES; LIVER DISEASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; SEVERE DENGUE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930944764     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2015.04.023     Document Type: Article

References (72)

1. Asare Y., Schmitt M., Bernhagen J. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thrombosis Haemostasis 2013, 109:391-398.
2. Assuncao-Miranda I., Amaral F.A., Bozza F.A., Fagundes C.T., Sousa L.P., Souza D.G., Pacheco P., Barbosa-Lima G., Gomes R.N., Bozza P.T., Da Poian A.T., Teixeira M.M., Bozza M.T. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 2010, 24:218-228.
3. Azeredo E.L., Zagne S.M., Santiago M.A., Gouvea A.S., Santana A.A., Neves-Souza P.C., Nogueira R.M., Miagostovich M.P., Kubelka C.F. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001, 204:494-507.
4. Becquart P., Wauquier N., Nkoghe D., Ndjoyi-Mbiguino A., Padilla C., Souris M., Leroy E.M. Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production. BMC Infect. Dis. 2010, 10:356.
5. Beltran D., Lopez-Verges S. NK cells during dengue disease and their recognition of dengue virus-infected cells. Frontiers Immunol. 2014, 5:192.
6. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., Bozza P.T., Kubelka C.F. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 2008, 8:86.
7. Bozza F.A., Gomes R.N., Japiassu A.M., Soares M., Castro-Faria-Neto H.C., Bozza P.T., Bozza M.T. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 2004, 22:309-313.
8. Braga E.L., Moura P., Pinto L.M., Ignacio S.R., Oliveira M.J., Cordeiro M.T., Kubelka C.F. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Memo. Inst. Oswaldo Cruz 2001, 96:229-232.
9. Brazilian-Federal-Government Saúde libera mais de R$ 360 mi para combate à dengue 2013, Brazilian-Federal-Government, Portal Brasil, Saúde., http://www.brasil.gov.br/saude/2013/11/saude-libera-mais-de-r-360-mi-para-combate-a-dengue.
10. Brazilian-Federal-Government Monitoramento dos casos de dengue e febre de chikungunya até a Semana Epidemiológica (SE) 47 de 2014, Portal Brasil, Saúde. Boletim Epidemiológico Secretaria de Vigilância em Saúde - Ministério da Saúde 2014, 45(31). http://portalsaude.saude.gov.br/images/pdf/2015/janeiro/02/2014-039---Dengue-SE-47.pdf.
11. Brazilian-Federal-Government Monitoramento dos casos de dengue e febre de chikungunya até a Semana Epidemiológica 9. Boletim Epidemiológico. Secretaria de Vigilância em Saúde - Ministério da Saúde 2015, 46(8). http://portalsaude.saude.gov.br/images/pdf/2015/marco/13/Boletim-Dengue-SE09-2015.final.pdf.
12. Brazilian-Health-Ministry Dengue: diagnóstico e manejo clínico - Adulto e Criança/Ministério da Saúde, Secretaria de Vigilância em Saúde. Diretoria Técnica de Gestão. - 3. ed. - Brasília: Ministério da Saúde, 2007. 28 p. (Série A. Normas e Manuais Técnicos) 2007, http://dtr2001.saude.gov.br/editora/produtos/livros/popup/dengue_diagnostico_manejo_adulto_crianca_3ed.html.
13. Brazilian-Health-Ministry Informe Epidemiológico da Dengue Janeiro a Novembro de 2008 2008, Secretaria de Vigilância em Saúde, http://www.combateadengue.com.br/wp-content/uploads/2009/02/boletim-janeiro-novembro-2008.pdf (accessed at 17.02.15).
14. Brazilian-Health-Ministry Secretaria de Vigilância em Saúde. Clipping - 13, 14 e 15 de novembro de 2010. Núcleo de Comunicação/SVS. 2010, http://portal.saude.gov.br/portal/arquivos/pdf/clipping_13_14_15_11_2010.pdf.
15. Butthep P., Chunhakan S., Yoksan S., Tangnararatchakit K., Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic Fever. Pediatric Infect. Dis. J. 2012, 31:e232-e238.
16. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
17. Cavalcanti L.P., Vilar D., Souza-Santos R., Teixeira M.G. Change in age pattern of persons with dengue, northeastern Brazil. Emerg. Infect. Dis. 2011, 17:132-134.
18. Chareonsirisuthigul T., Kalayanarooj S., Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J. Gen. Virol. 2007, 88:365-375.
19. Chen J.P., Lu H.L., Lai S.L., Campanella G.S., Sung J.M., Lu M.Y., Wu-Hsieh B.A., Lin Y.L., Lane T.E., Luster A.D., Liao F. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J. Immunol. 2006, 177:3185-3192.
20. Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., Lin Y.S., Wang S.T., Shyu H.W., Yeh T.M. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hygiene 2006, 74:142-147.
21. Chen R.F., Liu J.W., Yeh W.T., Wang L., Chang J.C., Yu H.R., Cheng J.T., Yang K.D. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 2005, 44:43-50.
22. Cordeiro M.T., Braga-Neto U., Nogueira R.M., Marques E.T. Reliable classifier to differentiate primary and secondary acute dengue infection based on IgG ELISA. PLoS One 2009, 4:e4945.
23. Couvelard A., Marianneau P., Bedel C., Drouet M.T., Vachon F., Henin D., Deubel V. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Human Pathol. 1999, 30:1106-1110.
24. de-Oliveira-Pinto L.M., Gandini M., Freitas L.P., Siqueira M.M., Marinho C.F., Setubal S., Kubelka C.F., Cruz O.G., Oliveira S.A. Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1beta and CCL2/MCP-1 in dengue fever and parvovirosis. Mem. Inst. Oswaldo Cruz 2012, 107:48-56.
25. de-Oliveira-Pinto L.M., Marinho C.F., Povoa T.F., de Azeredo E.L., de Souza L.A., Barbosa L.D., Motta-Castro A.R., Alves A.M., Avila C.A., de Souza L.J., da Cunha R.V., Damasco P.V., Paes M.V., Kubelka C.F. Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PLoS One 2012, 7:e38527.
26. Docke W.-D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H.-D., Kox W. Monocyte deactivation in septic patients: restoration by IFN-[gamma] treatment. Nat. Med. 1997, 3:678-681.
27. Fang X., Hu Z., Shang W., Zhu J., Xu C., Rao X. Genetic polymorphisms of molecules involved in host immune response to dengue virus infection. FEMS Immunol. Med. Microbiol. 2012, 66:134-146.
28. Fink J., Gu F., Ling L., Tolfvenstam T., Olfat F., Chin K.C., Aw P., George J., Kuznetsov V.A., Schreiber M., Vasudevan S.G., Hibberd M.L. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl. Trop. Dis. 2007, 1:e86.
29. Finton K.A., Strong R.K. Structural insights into activation of antiviral NK cell responses. Immunol. Rev. 2012, 250:239-257.
30. Giraldo D., Sant'Anna C., Périssé A.R.S., March M., Souza d.F.P., Mendes A.P., Bonfim A., Hofer M.C.B. Characteristics of children hospitalized with dengue fever in an outbreak in Rio de Janeiro, Brazil. Trans. R. Soc. Trop. Med. Hyg. 2011, 105:601-603.
31. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Rothman A.L., Ennis F.A. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 1999, 59:329-334.
32. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239:476-481.
33. Hober D., Poli L., Roblin B., Gestas P., Chungue E., Granic G., Imbert P., Pecarere J.L., Vergez-Pascal R., Wattre P., Maniez-Montreuil M. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am. J. Trop. Med. Hyg. 1993, 48:324-331.
34. Iyngkaran N., Yadav M., Sinniah M. Augmented inflammatory cytokines in primary dengue infection progressing to shock. Singapore Med. J. 1995, 36:218-221.
35. Kalayanarooj S., Vaughn D.W., Nimmannitya S., Green S., Suntayakorn S., Kunentrasai N., Viramitrachai W., Ratanachu-eke S., Kiatpolpoj S., Innis B.L., Rothman A.L., Nisalak A., Ennis F.A. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 1997, 176:313-321.
36. Khor C.C., Chau T.N., Pang J., Davila S., Long H.T., Ong R.T., Dunstan S.J., Wills B., Farrar J., Van Tram T., Gan T.T., Binh N.T., Tri le T., Lien le B., Tuan N.M., Tham N.T., Lanh M.N., Nguyet N.M., Hieu N.T., Van N.V.C.N., Thuy T.T., Tan D.E., Sakuntabhai A., Teo Y.Y., Hibberd M.L., Simmons C.P. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat. Genet. 2011, 43:1139-1141.
37. Kuno G., Bailey R.E. Cytokine responses to dengue infection among Puerto Rican patients. Memo. Inst. Oswaldo Cruz 1994, 89:179-182.
38. Kuo C.H., Tai D.I., Chang-Chien C.S., Lan C.K., Chiou S.S., Liaw Y.F. Liver biochemical tests and dengue fever. Am. J. Trop. Med. Hyg. 1992, 47:265-270.
39. Lee Y.R., Liu M.T., Lei H.Y., Liu C.C., Wu J.M., Tung Y.C., Lin Y.S., Yeh T.M., Chen S.H., Liu H.S. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 2006, 87:3623-3630.
40. Lehmann A.K., Halstensen A., Sornes S., Rokke O., Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect. Immun. 1995, 63:2109-2112.
41. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., de C., Ramos C., Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 1999, 73:4738-4747.
42. Limonta D., Capo V., Torres G., Perez A.B., Guzman M.G. Apoptosis in tissues from fatal dengue shock syndrome. J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol. 2007, 40:50-54.
43. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 2002, 14:129-135.
44. Malavige G.N., Huang L.C., Salimi M., Gomes L., Jayaratne S.D., Ogg G.S. Cellular and cytokine correlates of severe dengue infection. PLoS One 2012, 7:e50387.
45. Malavige G.N., Jeewandara C., Alles K.M., Salimi M., Gomes L., Kamaladasa A., Jayaratne S.D., Ogg G.S. Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Negl. Trop. Dis. 2013, 7:e2409.
46. Malhao T.A., Resende C.M., Gamerman D., Medronho Rde A. A Bayesian Model to Investigate Excess Mortality during the Dengue Epidemic in Greater Metropolitan Rio de Janeiro, Brazil, in 2007-2008 2013, vol. 29. Cadernos de saude publica/Ministerio da Saude, Fundacao Oswaldo Cruz, Escola Nacional de Saude Publica, pp. 2057-2070.
47. Mongkolsapaya J., Duangchinda T., Dejnirattisai W., Vasanawathana S., Avirutnan P., Jairungsri A., Khemnu N., Tangthawornchaikul N., Chotiyarnwong P., Sae-Jang K., Koch M., Jones Y., McMichael A., Xu X., Malasit P., Screaton G. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J. Immunol. 2006, 176:3821-3829.
48. Mortier A., Van Damme J., Proost P. Overview of the mechanisms regulating chemokine activity and availability. Immunol. Lett. 2012, 145:2-9.
49. Nascimento D., Castro A.R., Froes I.B., Bigaton G., Oliveira E.C., Dal Fabbro M.F., Cunha R.V., Costa I.P. Clinical and laboratory findings in patients with dengue associated with hepatopathy. Rev. Soc. Brasileira Med. Trop. 2011, 44:674-677.
50. Neves-Souza P.C., Azeredo E.L., Zagne S.M., Valls-de-Souza R., Reis S.R., Cerqueira D.I., Nogueira R.M., Kubelka C.F. Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection. BMC Infect. Dis. 2005, 5:64.
51. Neville L.F., Mathiak G., Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev. 1997, 8:207-219.
52. Nguyen T.H., Lei H.Y., Nguyen T.L., Lin Y.S., Huang K.J., Le B.L., Lin C.F., Yeh T.M., Do Q.H., Vu T.Q., Chen L.C., Huang J.H., Lam T.M., Liu C.C., Halstead S.B. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 2004, 189:221-232.
53. Oliveira M.F., Galvao Araujo J.M., Ferreira O.C., Ferreira D.F., Lima D.B., Santos F.B., Schatzmayr H.G., Tanuri A., Ribeiro Nogueira R.M. Two lineages of dengue virus type 2, Brazil. Emerg. Infect. Dis. 2010, 16:576-578.
54. Pagliari C., Quaresma J.A., Fernandes E.R., Stegun F.W., Brasil R.A., de Andrade H.F., Barros V., Vasconcelos P.F., Duarte M.I. Immunopathogenesis of dengue hemorrhagic fever: contribution to the study of human liver lesions. J. Med. Virol. 2014, 86:1193-1197.
55. Perez A.B., Garcia G., Sierra B., Alvarez M., Vazquez S., Cabrera M.V., Rodriguez R., Rosario D., Martinez E., Denny T., Guzman M.G. IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J. Med. Virol. 2004, 73:230-234.
56. Pires Neto Rda J., de Sa S.L., Pinho S.C., Pucci F.H., Teofilo C.R., Evangelista P.D., The C.S., Bezerra D.E., Lima J.C., Ponte H.J., Daher Ede F., Coelho I.C. Dengue infection in children and adolescents: clinical profile in a reference hospital in northeast Brazil. Rev. Soc. Brasil. Med. Trop. 2013, 46:765-768.
57. Quirico-Santos T., Da-Cruz A.M., Kubelka C.F., Lannes J., Moraes M.O. 28. Tropical Diseases. Cytokine Gene Polymorphisms in Multifatorial Conditions 2006, 413-429. CRC Press LLC, London. H. Vanderbroeck (Ed.).
58. Rathakrishnan A., Wang S.M., Hu Y., Khan A.M., Ponnampalavanar S., Lum L.C.S., Manikam R., Sekaran S.D. Cytokine expression profile of dengue patients at different phases of illness. PLoS One 2012, 7:e52215.
59. Salazar-Mather T.P., Hamilton T.A., Biron C.A. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 2000, 105:985-993.
60. Souza L.J., Alves J.G., Nogueira R.M., Gicovate Neto C., Bastos D.A., Siqueira E.W., Souto Filho J.T., Cezario Tde A., Soares C.E., Carneiro Rda C. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz. J. Infect. Dis.: Off. Publ. Braz. Soc. Infect. Dis. 2004, 8:156-163.
61. Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thrombosis Haemostasis 2009, 102:1042-1049.
62. Sung J.M., Lee C.K., Wu-Hsieh B.A. Intrahepatic infiltrating NK and CD8 T cells cause liver cell death in different phases of dengue virus infection. PLoS One 2012, 7:e46292.
63. Tolfvenstam T., Lindblom A., Schreiber M.J., Ling L., Chow A., Ooi E.E., Hibberd M.L. Characterization of early host responses in adults with dengue disease. BMC Infect. Dis. 2011, 11:209.
64. Trung D.T., Thao le T.T., Hien T.T., Hung N.T., Vinh N.N., Hien P.T., Chinh N.T., Simmons C., Wills B. Liver involvement associated with dengue infection in adults in Vietnam. Am. J. Trop. Med. Hyg. 2010, 83:774-780.
65. Vitarana T., de Silva H., Withana N., Gunasekera C. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med. J. 1991, 36:63-65.
66. Wahid S.F., Sanusi S., Zawawi M.M., Ali R.A. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J. Trop. Med. Publ. Health 2000, 31:259-263.
67. WHO Dengue Hemorrahagic Fever Diagnosis Treatment and Control 1997, WHO, Geneva, http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/. 2nd ed.
68. WHO/TDR Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control - New edition. World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR) 2009, http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
69. Xavier-Carvalho C., Gibson G., Brasil P., Ferreira R.X., de Souza Santos R., Goncalves Cruz O., de Oliveira S.A., de Sa Carvalho M., Pacheco A.G., Kubelka C.F., Moraes M.O. Single nucleotide polymorphisms in candidate genes and dengue severity in children: a case-control, functional and meta-analysis study. Infect. Genet. Evol.: J. Mol. Epidemiol. Evolut. Genet. Infect. Dis. 2013, 20:197-205.
70. Yacoub S., Mongkolsapaya J., Screaton G. The pathogenesis of dengue. Curr. Opin. Infect. Dis. 2013, 26:284-289.
71. Yeo A.S., Azhar N.A., Yeow W., Talbot C.C., Khan M.A., Shankar E.M., Rathakrishnan A., Azizan A., Wang S.M., Lee S.K., Fong M.Y., Manikam R., Devi Sekaran S. Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes. PLoS One 2014, 9:e92240.
72. Zagne S.M., Alves V.G., Nogueira R.M., Miagostovich M.P., Lampe E., Tavares W. Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:677-679.